Literature DB >> 15003199

Intraoperative radiotherapy for breast cancer.

Jayant S Vaidya1, Jeffrey S Tobias, Michael Baum, Mohammed Keshtgar, David Joseph, Frederik Wenz, Joan Houghton, Christobel Saunders, Tammy Corica, Derek D'Souza, Richard Sainsbury, Samuele Massarut, Irving Taylor, Basil Hilaris.   

Abstract

Postoperative radiotherapy, which forms part of breast-conserving therapy, may not need to encompass the whole breast. Apart from the consumption of huge resources and patients' time, postoperative radiotherapy deters many women from receiving the benefits of breast-conserving surgery, forcing them to choose a mastectomy instead. If radiotherapy could be given in the operating theatre immediately after surgery, many of these disadvantages could be overcome. One striking fact about local recurrence after breast-conserving surgery is that most occurs in the area of breast immediately next to the primary tumour; this is despite the finding that two-thirds of mastectomy samples have microscopic tumours distributed throughout the breast, even when radiotherapy is omitted. Thus, only the area adjacent to the tumour may need treatment with radiotherapy. On the basis of this premise, clinical scientists have used new technology to administer radiotherapy to the area at greatest risk of local recurrence, with the aim of completing the whole local treatment in one sitting. In this review, we have elaborated on the rationale and different methods of delivery of intraoperative radiotherapy. If this approach is validated by the results of current randomised trials, it could save time, money, and breasts.

Entities:  

Mesh:

Year:  2004        PMID: 15003199     DOI: 10.1016/S1470-2045(04)01412-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  24 in total

1.  Radiobiological comparison of hypofractionated accelerated partial-breast irradiation (APBI) and single-dose intraoperative radiotherapy (IORT) with 50-kV X-rays.

Authors:  Carsten Herskind; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2010-07-29       Impact factor: 3.621

Review 2.  Management of breast cancer--part I.

Authors:  Nicholas C Turner; Alison L Jones
Journal:  BMJ       Date:  2008-07-04

Review 3.  Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date.

Authors:  G G Hanna; A M Kirby
Journal:  Br J Radiol       Date:  2015-03-03       Impact factor: 3.039

Review 4.  Recent developments and best practice in brachytherapy treatment planning.

Authors:  C D Lee
Journal:  Br J Radiol       Date:  2014-06-02       Impact factor: 3.039

5.  Risk factors for seroma evacuation in breast cancer patients treated with intraoperative radiotherapy.

Authors:  Michał Falco; Bartłomiej Masojć; Magdalena Rolla; Agnieszka Czekała; Jolanta Pietruszewska; Agnieszka Rubik-Leszczyńska; Mirosław Lewocki; Magdalena Łukowiak; Andrzej Kram
Journal:  Rep Pract Oncol Radiother       Date:  2016-03-29

6.  Intraoperative radiotherapy (IORT) versus whole-breast external beam radiotherapy (EBRT) in early stage breast cancer: results from SEER database.

Authors:  Juan Lei; Yi Wang; Zhuofei Bi; Shengneng Xue; Bing Ou; Kan Liu
Journal:  Jpn J Radiol       Date:  2019-11-05       Impact factor: 2.374

Review 7.  Function-preserving surgery for breast cancer.

Authors:  Hideo Inaji; Chiyomi Egawa; Yoshifumi Komoike; Kazuyoshi Motomura; Kinji Nishiyama; Tatsuki R Kataoka; Hiroki Koyama
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

8.  A phase I study of intraoperative radiotherapy for early breast cancer in Japan.

Authors:  Masataka Sawaki; Shigenori Sato; Toyone Kikumori; Shunichi Ishihara; Yuichi Aoyama; Yoshiyuki Itoh; Akimasa Nakao; Tsuneo Imai
Journal:  World J Surg       Date:  2009-12       Impact factor: 3.352

Review 9.  Accelerated Partial Breast Irradiation (APBI): A review of available techniques.

Authors:  Christopher F Njeh; Mark W Saunders; Christian M Langton
Journal:  Radiat Oncol       Date:  2010-10-04       Impact factor: 3.481

10.  A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17.

Authors:  Douglas W Arthur; Kathryn Winter; Robert R Kuske; John Bolton; Rachel Rabinovitch; Julia White; William F Hanson; Raymond M Wilenzick; Beryl McCormick
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-04       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.